Oxoid acquires Dako's Microbiology business
Oxoid, a business unit within the Fisher Biosciences group, has acquired Dako's microbiology business. The purchase expands Oxoid's range of clinical microbiology products for the detection of viral gastroenteritis, sexually transmitted diseases, respiratory diseases, Lyme disease and Helicobacter pylori, which is supplemented by a range of specialist ELISA tests for veterinary use.
From September 1, 2006 Dako's microbiology range will gradually be rebranded as Oxoid and products should be ordered via Oxoid's headquarters in Basingstoke, UK or through Oxoid's local sales offices. Oxoid will continue to manufacture the products in Ely, Cambridgeshire (UK). OEM customers will continue to be serviced from the Ely site. The financial details of the acquisition have not been disclosed.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
